Skip Nav Destination
Issues
1 December 2009
-
Cover Image
Cover Image
Representative clone of BT-474R cells showing positive immunohistochemistry staining for the HER2 receptor. For further details, please see Mittendorf and colleagues on page 7381 in this issue.Close Modal - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
CCR Translations
Molecular Pathways
Human Cancer Biology
Cancer Therapy: Preclinical
A High-Affinity Fully Human Anti–IL-6 mAb, 1339, for the Treatment of Multiple Myeloma
Mariateresa Fulciniti; Teru Hideshima; Claudine Vermot-Desroches; Samantha Pozzi; Puru Nanjappa; Zhenxin Shen; Nipun Patel; Ernest S. Smith; Wei Wang; Rao Prabhala; Yu-tzu Tai; Pierfrancesco Tassone; Kenneth C. Anderson; Nikhil C. Munshi
Interactions of the Hdm2/p53 and Proteasome Pathways May Enhance the Antitumor Activity of Bortezomib
Melissa G. Ooi; Patrick J. Hayden; Vassiliki Kotoula; Douglas W. McMillin; Elpida Charalambous; Emily Daskalaki; Noopur S. Raje; Nikhil C. Munshi; Dharminder Chauhan; Teru Hideshima; Leutz Buon; Martin Clynes; Peter O'Gorman; Paul G. Richardson; Constantine S. Mitsiades; Kenneth C. Anderson; Nicholas Mitsiades
E7080, a Multi–Tyrosine Kinase Inhibitor, Suppresses the Progression of Malignant Pleural Mesothelioma with Different Proangiogenic Cytokine Production Profiles
Kenji Ikuta; Seiji Yano; Van The Trung; Masaki Hanibuchi; Hisatsugu Goto; Qi Li; Wei Wang; Tadaaki Yamada; Hirokazu Ogino; Soji Kakiuchi; Hisanori Uehara; Yoshitaka Sekido; Toshimitsu Uenaka; Yasuhiko Nishioka; Saburo Sone
High-Throughput Screening Identifies Two Classes of Antibiotics as Radioprotectors: Tetracyclines and Fluoroquinolones
Kwanghee Kim; Julianne M. Pollard; Andrew J. Norris; J. Tyson McDonald; Yingli Sun; Ewa Micewicz; Kelly Pettijohn; Robert Damoiseaux; Keisuke S. Iwamoto; James W. Sayre; Brendan D. Price; Richard A. Gatti; William H. McBride
A Novel Synergistic Combination of Cyclophosphamide and Gene Transfer of Interleukin-12 Eradicates Colorectal Carcinoma in Mice
Mariana Malvicini; Miguel Rizzo; Laura Alaniz; Federico Piñero; Mariana García; Catalina Atorrasagasti; Jorge B. Aquino; Viviana Rozados; O. Graciela Scharovsky; Pablo Matar; Guillermo Mazzolini
Inhibition of Mammalian Target of Rapamycin Is Required for Optimal Antitumor Effect of HER2 Inhibitors against HER2-Overexpressing Cancer Cells
Todd W. Miller; James T. Forbes; Chirayu Shah; Shelby K. Wyatt; H. Charles Manning; Maria G. Olivares; Violeta Sanchez; Teresa C. Dugger; Nara de Matos Granja; Archana Narasanna; Rebecca S. Cook; J. Phillip Kennedy; Craig W. Lindsley; Carlos L. Arteaga
ABT-888 Confers Broad In vivo Activity in Combination with Temozolomide in Diverse Tumors
Joann P. Palma; Yi-Chun Wang; Luis E. Rodriguez; Debra Montgomery; Paul A. Ellis; Gail Bukofzer; Amanda Niquette; Xuesong Liu; Yan Shi; Loren Lasko; Gui-Dong Zhu; Thomas D. Penning; Vincent L. Giranda; Saul H. Rosenberg; David J. Frost; Cherrie K. Donawho
Imaging, Diagnosis, Prognosis
Pro–Prostate-Specific Antigen Measurements in Serum and Tissue Are Associated with Treatment Necessity among Men Enrolled in Expectant Management for Prostate Cancer
Danil V. Makarov; Sumit Isharwal; Lori J. Sokoll; Patricia Landis; Cameron Marlow; Jonathan I. Epstein; Alan W. Partin; H. Ballentine Carter; Robert W. Veltri
KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803
Shuji Ogino; Jeffrey A. Meyerhardt; Natsumi Irahara; Donna Niedzwiecki; Donna Hollis; Leonard B. Saltz; Robert J. Mayer; Paul Schaefer; Renaud Whittom; Alexander Hantel; Al B. Benson, III; Richard M. Goldberg; Monica M. Bertagnolli; Charles S. Fuchs; for the Cancer and Leukemia Group B, North Central Cancer Treatment Group, Canadian Cancer Society Research Institute, Southwest Oncology Group
KIR and HLA Genotypes Are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk Neuroblastoma
Jeffrey M. Venstrom; Junting Zheng; Nabila Noor; Karen E. Danis; Alice W. Yeh; Irene Y. Cheung; Bo Dupont; Richard J. O'Reilly; Nai-Kong V. Cheung; Katharine C. Hsu
Cancer Therapy: Clinical
Randomized Trial and Pharmacokinetic Study of Pegfilgrastim versus Filgrastim after Dose-Intensive Chemotherapy in Young Adults and Children with Sarcomas
Elizabeth Fox; Brigitte C. Widemann; Douglas S. Hawkins; Nalini Jayaprakash; Ramzi Dagher; Alberta A. Aikin; Donna Bernstein; Lauren Long; Crystal Mackall; Lee Helman; Seth M. Steinberg; Frank M. Balis
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of CH4987655 in Healthy Volunteers: Target Suppression Using a Biomarker
Lucy Lee; Huifeng Niu; Ruediger Rueger; Yuriko Igawa; Jonathan Deutsch; Nobuya Ishii; Song Mu; Yuuichiro Sakamoto; Rachel Busse-Reid; Claude Gimmi; Petra Goelzer; Stefanie De Schepper; Yashushi Yoshimura; Joanne Barrett; Yuji Ishikawa; Georges Weissgerber; Richard Peck
Phase I Clinical Trial of an Adenovirus/Prostate-Specific Antigen Vaccine for Prostate Cancer: Safety and Immunologic Results
David M. Lubaroff; Badrinath R. Konety; Brian Link; Jack Gerstbrein; Tammy Madsen; Mary Shannon; Jeanne Howard; Jennifer Paisley; Diana Boeglin; Timothy L. Ratliff; Richard D. Williams
Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes
Elizabeth A. Mittendorf; Yun Wu; Maurizio Scaltriti; Funda Meric-Bernstam; Kelly K. Hunt; Shaheenah Dawood; Francisco J. Esteva; Aman U. Buzdar; Huiqin Chen; Sameena Eksambi; Gabriel N. Hortobagyi; Jose Baselga; Ana M. Gonzalez-Angulo
Expression of Epidermal Growth Factor Receptor (EGFR) and Activated EGFR Predict Poor Response to (Chemo)radiation and Survival in Cervical Cancer
Maartje G. Noordhuis; Jasper J.H. Eijsink; Klaske A. ten Hoor; Frank Roossink; Harry Hollema; Henriëtte J.G. Arts; Elisabeth Pras; John H. Maduro; Anna K.L. Reyners; Geertruida H. de Bock; G. Bea A. Wisman; Ed Schuuring; Ate G.J. van der Zee
Phase I Study of Flavopiridol with Oxaliplatin and Fluorouracil/Leucovorin in Advanced Solid Tumors
Dana Rathkopf; Mark A. Dickson; Darren R. Feldman; Richard D. Carvajal; Manish A. Shah; Nian Wu; Robert Lefkowitz; Mithat Gonen; Lauren M. Cane; Heather J. Dials; Jennifer L. Winkelmann; George J. Bosl; Gary K. Schwartz
Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer
Evan Y. Yu; George Wilding; Edwin Posadas; Mitchell Gross; Stephane Culine; Christophe Massard; Michael J. Morris; Gary Hudes; Fabio Calabrò; Shinta Cheng; Géralyn C. Trudel; Prashni Paliwal; Cora N. Sternberg
Susceptibility and Prevention
Letters to the Editor
Corrections
Advertisement